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Abstract Low folate intake is associated with vascular
disease. Causality has been attributed to hyperhomocystei-
nemia. However, human intervention trials have failed to
show the benefit of homocysteine-lowering therapies.
Alternatively, low folate may promote vascular disease by
deregulating DNA methylation. We investigated whether
folate could alter DNA methylation and atherosclerosis in
ApoE null mice. Mice were fed one of six diets (n=20 per
group) for 16 weeks. Basal diets were either control (C; 4%
lard) or high fat (HF; 21% lard and cholesterol, 0.15%)
with different B-vitamin compositions: (1) folic acid and B-
vitamin replete, (2) folic acid deficient (−F), (3) folic acid,
B6 and B12 deficient (−F−B). −F diets decreased plasma
(up to 85%; P<0.05), whole blood (up to 70%; P<0.05),
and liver folate (up to 65%; P<0.05) and hepatic SAM/SAH
(up to 80%; P<0.05). −F−B diets reduced plasma (up to
76%; P<0.05), whole blood (up to 72%; P<0.05), and liver
B12 (up to 39%; P<0.05) and hepatic SAM/SAH
(up to 90%; P<0.05). −F increased homocysteine 2-fold,
while −F−B increased homocysteine 3.6- and 6.8-fold in
the C and HF groups (P<0.05). Plaque formation was
increased 2-fold (P<0.0001) in mice fed a HF diet. Feeding
aH F –F diet increased lesion formation by 17% (P<0.05).
There was no change in 5-methyldeoxycytidine in liver or
vascular tissue (aorta, periadventitial tissue and heart).
These data suggest that atherogenesis is not associated
with genome-wide epigenetic changes in this animal model.
Keywords Folic acid and B-vitamin deficiency in ApoE
null mice.Atherosclerosis.Aortic plaques.
Hyperhomocysteinemia.Genome-wide DNA methylation.
Vascular tissue
Introduction
Suboptimal B-vitamin intake is strongly associated with
predisposition to vascular disease in humans (Boushey et al.
1995; Verhaar et al. 2002; McNulty et al. 2008). Low
intracellular folate and vitamin B12 induce hyperhomocystei-
nemia by retarding methionine remethylation. Not only is
homocysteine cardiotoxic, it causes endoplasmic reticular
stress, lipid oxidation and impaired thrombolysis and vasodi-
lation (Werstruck et al. 2001; Castro et al. 2006). Additionally,
it induces vascular smooth muscle cell (SMC) proliferation
and monocyte chemotaxis (Splaver et al. 2004). Most human
observational studies support a positive association between
homocysteine and heart disease (Splaver et al. 2004;
Homocysteine Studies Collaboration 2002). One early meta-
analysis of studies reported a significant increase in CVD risk
(60% for men and 80% for women) for each 5-μmol/L
increase in circulating homocysteine (Boushey et al. 1995).
Subsequent meta-examination of prospective studies described
a reduced risk of ischemic heart disease (11%) and stroke
(19%) associated with a 25% drop in plasma homocysteine
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DOI 10.1007/s13148-011-0022-x(Homocysteine Studies Collaboration 2002). In contrast,
recent large-scale intervention trials have failed to show any
benefit of homocysteine-lowering therapies against death from
cardiovascular causes in patients either with pre-existing
vascular disease or diabetes despite baseline homocysteine
predicting subsequent vascular events (Homocysteine Studies
Collaboration 2002; HOPE 2 2006; Wierzbicki 2007).
Consequently, there is considerable controversy as to whether
homocysteine is causal for vascular disease (Splaver et al.
2004). An alternative viewpoint is that homocysteine serves
merely as a functional indicator of low folate status. Two
prospective studies of men without CVD observed that high
serum folate was associated with a significantly reduced risk
of subsequent coronary events (Voutilainen et al. 2000, 2004).
Homocysteine was not associated with risk (Voutilainen et al.
2004). Moreover, intervention with folic acid positively
influences surrogate endpoints of vascular function (abnormal
exercise ECG tests and flow-mediated dilatation) in patients
with CVD, supporting an independent role for folate in
vascular health (Vermeulen et al. 2000; Doshi et al. 2002;
Woo et al. 2002).
Folate is critical in generating S-adenosylmethionine
(SAM) for DNA methylation. Genes methylated at specific
sites (e.g. upstream of a promoter) are either not transcribed
or transcribed at a reduced rate. Epigenetic DNA methyl-
ation therefore contributes to the control of gene and
ultimately protein expression (Costello and Plass 2001).
Folate deficiency, by inhibiting normal DNA methylation,
may disrupt this function.
It is accepted that aberrant DNA methylation is involved
in human cancer. The role of abnormal DNA methylation in
the pathogenesis of vascular disease is largely unknown.
Altered DNA methylation, as a consequence of suboptimal
folate status, may be a common mechanism linking
malignant transformation and vascular dysfunction. The
atherosclerotic plaque and the tumour are both monoclonal
in origin with aberrant DNA methylation and the expres-
sion of genes regulating cell proliferation providing a
growth advantage for selected clones. During atherogene-
sis, SMCs transform from a contractile to a synthetic
phenotype and migrate and proliferate into the intima.
Over-expression of growth factors and pro-proliferative
oncogenes such as c-myc and p53 drive SMC invasiveness.
In addition, over-expression of genes regulating lipid
metabolism, connective tissue formation, calcification and
inflammation accelerates plaque progression (Dong et al.
2002; Zaina et al. 2005; Turunen et al. 2009).
Determining whether abnormal DNA methylation causes
plaque development in vivo is extremely difficult due to the
intimate metabolic relationship between folate, homocys-
teine and cytosine methylation. We have recently developed
a transgenic ApoE knockout mouse model demonstrating
either mild or moderate hyperhomocysteinemia. Here, we
describe how folate deficiency affects genomic DNA
methylation in vascular tissue and aortic plaque formation
in these mice, largely independently of increasing plasma
homocysteine.
Methods
Animals and diets
Male ApoE-/- mice (n=120, aged 4 weeks), congenic with
C57BL/6J mice, were obtained from Charles River, UK
(Margate, UK) and housed individually on grid floors to
prevent coprophagy. All the mice were fed standard
laboratory chow ad libitum for 1 week acclimatisation
before being assigned (by weight) to experimental diets (n=
20 animals per group). Six diets were prepared based on
AIN 93M recommendations but with different levels of fat/
cholesterol and B vitamins. Two basal diets were designat-
ed either as control (C; 4% w/w lard) or high fat (HF; 21%
w/w lard and cholesterol, 0.15% w/w). Different B-vitamin
compositions were applied to each of these diets: (1) folic
acid and B-vitamin replete, (2) folic acid deficient (−F) or
(3) folic acid, B6 and B12 deficient (−F−B). Dietary
composition is shown in Tables 1 and 2. Diets were
prepared by Special Diets Services (UK). Powdered diet
was reconstituted by adding glycerol (10% w/w)a n d
distilled H2O (36% w/w control-fat diet or 18% w/w high-
fat diet), frozen, lyophilised and stored at −20°C. Mice
were fed ad libitum and allowed free access to water
throughout the experiment. Animals were weighed three
times weekly. Food intake was monitored at weeks 1, 8 and
16. All procedures were carried out in accordance with the
requirements of UK Animals (Scientific Procedures) Act
1986.
Table 1 Composition of experimental diets (grams per kilogram)
Diet Control fat (C) High fat (HF)
Casein 140 140
Cellulose 50 50
Corn starch 466 296
Cholesterol 0 1.5
Choline bitartrate 2.5 2.5
Cystine 1.8 1.8
Lard 0 170
Maltodextrin 155 155
Sucrose 100 100
Soya bean oil 40 40
TBHQ antioxidant 0.008 0.008
Mineral mix (AIN-93M-Mx) 35 35
Vitamin mix (AIN-93-VX) 10 10
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After 16 weeks on experimental diet, mice (fasted for 4–
6 h) were killed by i.p. injection of a lethal dose of sodium
pentobarbital and exsanguination under terminal anaesthe-
sia. Whole blood was immediately collected from the vena
cava into a heparinised syringe for analysis of folate and for
plasma preparation (see below). Residual blood was flushed
from the tissues by injection of DMEM (5 ml) into the left
ventricle of the heart. The liver was collected and snap
frozen for analysis of folate, B12 and DNA methylation or
in perchloric acid (PCA) for analyses of SAM and S-
Adenosyl-L-homocysteine (SAH) (Duthie et al. 2010). The
aorta and heart were removed carefully from the chest, as
described previously, and placed in a Petri dish containing
DMEM (Beattie et al. 2009). The aorta was separated from
the heart, flushed with DMEM using a 25-gauge needle and
syringe and microdissected (using a dissecting microscope)
of all tunica adventitia and adipose tissue. The aorta was cut
at the interface between the thoracic arch and abdominal
section, and the arch was placed in 10% formalin. The
abdominal section of the aorta, the adventitia and a small
portion of heart were snap frozen in liquid nitrogen, for
DNA methylation analysis. After 24 h, the fixed aortic
arches were removed from formalin, blotted dry, snap
frozen and stored at −80°C for plaque analysis.
Atherosclerotic plaque analysis
Atherosclerotic lesions in the aortic arch were measured as
described in detail previously (Beattie et al. 2009). Aortic
lesions are quantified by staining plaques in situ with the
neutral lipid-targeting lysochrome Oil Red O (ORO; Sigma,
Poole, UK) that targets fatty deposits in the arterial plaques
and solubilising and quantifying spectrophotometrically the
dye retained by the aorta (Beattie et al. 2009). Solubilised
ORO as a biomarker of atherosclerotic plaque volume was
corrected for tissue weight.
B vitamin, total plasma homocysteine and SAM/SAH status
Whole blood (100 μl) was incubated with ascorbic acid
(0.9 ml, 1% w/v) for 1.5 h in the dark, snap frozen in liquid
nitrogen and stored at −80°C for folate and B12 analysis
(Duthie et al. 2010). The remaining blood was centrifuged
at 2,400×g for 15 min at 4°C, and the plasma aliquoted,
snap frozen and stored as above. Whole blood, plasma
folate and plasma B12 were determined by radioassay
(Duthie et al. 2010). Plasma homocysteine was measured
by gas chromatography (Duthie et al. 2010). Liver SAM
and SAH were measured in PCA-treated samples by HPLC
(Wang et al. 2001).
Genome-wide DNA methylation in vascular tissue
and liver
DNA was isolated from mouse aorta, adventitia, heart and
liver using a Nucleospin C&T kit (Abgene Ltd, Epsom,
UK). 5-Methyldeoxycytosine levels were quantified by LC
MS/MS (Duthie et al. 2010; Friso et al. 2002).
Statistical analysis
Data are presented as means±SEM with the number of
animals in parenthesis. Data were analysed by two-way
ANOVA for the effect of fat intake, vitamin composition
and interaction between these factors. Significant differ-
ences between all groups were detected using the least
significant difference (LSD) post-hoc method for P<0.05.
Data not sharing superscript letters differ significantly.
Analyses were carried out using SPSS (version 17).
Results
B vitamin and methyl donor status
Mice fed the HF Westernised diet ate approximately 30%
less than animals fed the C fat diet (data not shown). Folate
deficiency alone had no effect on body weight in either the
C or HF groups. Conversely, animals fed the −F−B-
deficient diet gained body weight at a slower rate compared
with animals fed a −F diet (P<0.05; Fig. 1). This effect was
exacerbated by HF (P<0.05; Fig. 1). No behavioural or
pathological abnormalities were observed in any of the
animals (data not shown).
Plasma, whole blood and liver folate concentrations were
profoundly dependent on dietary folic acid and were
influenced to a limited extent by fat intake (Table 3).
Plasma (but not whole blood or liver) folate was signifi-
cantly higher in mice fed the HF vitamin-replete diet for
16 weeks compared with animals fed C fat (P<0.05;
Table 3). Plasma folate declined 82% and 85% in mice fed
the C−F and HF−F diets, respectively (P<0.05; Table 3);
whole blood folate decreased approx. 67% and 70% (P<
0.05; Table 3), and liver folate was depleted by 55% and
64% in these groups (Table 3). Feeding a −F−B diet did not
Table 2 Composition of vitamin mix (grams per kilogram)
C/HF −F −F−B
Folic acid 0.2 0 0
Vitamin B6 0.7 0.7 0
Vitamin B12 2.5 2.5 0
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deficiency alone (Table 3).
Circulating B12 was affected differentially by −Fo r
−F−B deficiency. Plasma B12 was depleted by 73%
in the C group and by 76% in the HF group by feeding a
−F−Bd i e t( P<0.0001; Table 3). Feeding a −Fd i e ta l o n e
depleted plasma B12 38% and 51% respectively in these
groups (P<0.05; Table 3). HF exacerbated the effect
of −Fa n d−F−B deficiency on plasma B12 (P<0.0001;
Table 3). Feeding a −F diet alone did not influence whole
blood B12 in mice fed C fat but did induce a significant
drop in B12 in animals fed a HF diet (P<0.05; Table 3).
Feeding a −F−B diet decreased liver B12 by 35% and
39% in the C and HF groups, respectively (P<0.001;
Table 3). Feeding a −F−B diet induced a more severe
hepatic B12 depletion irrespective of fat intake (P>0.05;
Table 3).
The ratio of hepatic SAM to SAH was significantly
decreased in mice fed a −F diet for 16 weeks (approx. 75%
in the C fat group and 80% in the HF group; P<0.0001;
Table 3). Combined −F−B deficiency reduced the SAM/
SAH ratio even further (P<0.05) (Fig. 2).
Folate deficiency increased plasma homocysteine 2.3-
fold in the C−F and 2.1-fold in the HF−F diet. Feeding a
combined −F−B diet induced hyperhomocysteinemia to a
greater extent (3.6- and 6.8-fold in the C and HF groups,
respectively). This augmentation was significantly depen-
dent on fat intake (P<0.05 for all data; Fig. 3).
Plaque formation
Plaque development was increased (approximately 2.0-fold;
P<0.0001) in mice fed a Westernised HF diet compared
with animals fed a C fat diet (Fig. 4). Folate deficiency
increased lesion formation in the HF−F group (17%; P<
0.05). Feeding on a HF−F−B diet did not accelerate plaque
formation further (Fig. 4).
DNA methylation
Genome-wide DNA methylation was measured in the
cleaned aorta, tunica adventitia, heart and liver from −F
and −F−B-deficient animals fed a C or HF diet. 5-
methyldeoxycytidine concentrations and percentage meth-
ylated DNA (calculated as a percentage of total cytosines in
the DNA) were similar for all treatment groups (P>0.05;
Table 4).
Discussion
Low folate intake and low folate blood concentrations are
associated with an increased risk of vascular disease
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Fig. 1 The effect of folic acid, B vitamins and fat intake on growth.
Results are mean body weight±SEM after 16 weeks on experimental
diet for n=17–20 animals per group. Data not sharing superscript
letters differ by P<0.05
Table 3 Indices of methyl donor status in blood and tissues from ApoE mice fed a control (C) or high fat (HF) diet depleted of folic acid (F−)o r
folic acid and vitamins B6 and B12 (F−B−) for 16 weeks
Control fat High fat
CC −FC −F−BH F H F −FH F −F−B
Plasma folate (ng/ml) 87.8±4.8
a 16.2±1.5
b 14.9±0.9
b 104.9±5.5
c 15.5±1.7
b 15.0±1.4
b
Whole blood folate (ng/ml) 498.9±42.9
a 163.5±8.9
b 184.7±6.8
b 507.9±26.0
a 149.6±9.7
b 193.3±18.7
b
Liver folate (ng/mg protein) 106.0±8.0
a 47.1±2.8
b 50.2±3.6
b 117.1±8.3
a 42.0±2.3
b 41.1±1.6
b
Plasma B12 (ng/mg) 24.8±2.3
a 15.3±1.0
b 6.8±0.1
c 25.6±3.0
a 12.5±0.5
d 6.1±0.5
c
Whole blood B12 (ng/ml) 22.5±1.0
a,c 22.0±0.6
a,c 7.2±0.7
b 24.9±1.6
a 20.5±1.1
c 6.9±1.0
b
Liver B12 (ng/g protein) 1.49±0.05
a 1.43±0.11
a 0.96±0.04
b 1.38±0.09
a 1.18±0.09
c 0.84±0.04
b
Liver SAM (nmol/g tissue) 100.2±9.2
a 50.7±4.0
b 43.7±2.6
c 84.1±4.7
d 47.6±6.7
b 36.1±1.8
c
Liver SAH (nmol/g tissue) 50.4±2.3
a 71.6±3.1
b 86.1±4.3
c 47.6±3.1
a 68.1±3.8
b 89.7±4.4
c
Values are means±SEM for n=10 mice sampled per group. Data not sharing superscript letters differ by P<0.05
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2008). Historically, causality has been attributed to high
circulating homocysteine, which is cardiotoxic and dereg-
ulates vascular cell integrity and function (Werstruck et al.
2001; Castro et al. 2006). Low folate may also promote
or accelerate vascular disease by deregulating DNA
methylation, gene expression and cellular metabolism
(Dong et al. 2002; Zaina et al. 2005; Turunen et al.
2009). 5-methyltetrahydrofolate remethylates homocys-
teine to methionine, which is further metabolised to
S-adenosylmethionine (SAM), the principal 1-C donor in
the methylation of cytosine. Under conditions of low
dietary folate, SAM is depleted causing hypomethylation
of DNA and abnormal gene expression. Aberrant cytosine
methylation and proto-oncogene activation may be causal
in vascular dysfunction.
The primary aims of this study were to determine
whether folate status, independently of homocysteine,
would increase vascular disease in vivo and to further
establish whether abnormal genome-wide DNA methyla-
tion in the vasculature was causal. We developed a
nutritional model of mild and moderate hyperhomocystei-
nemia in order to try to determine the differential effects of
folate deficiency and homocysteine on plaque formation.
Feeding ApoE null mice a −F diet for 16 weeks caused
moderate intracellular folate deficiency. As expected, blood
and cellular B12 were significantly decreased in animals
fed the combined −F−B-deficient diet. Additionally, folate
deficiency alone induced a significant reduction in B12
status (approx. 40–50% depending on fat intake; Table 3).
Prolonged folate deficiency has been found previously to
induce serum B12 depletion in rats (Hsu et al. 1962). This
appears to be due to altered B12 transport, metabolism and
utilisation, rather than via impaired intestinal absorption
(Hsu et al. 1962). Folate deficiency may similarly disrupt
B12 absorption, metabolism and excretion in humans (Van
Royen et al. 1978; Cattan et al. 1982; Dawson et al. 1984).
A similar pattern of effect was measured in hepatic SAM
and SAH in response to −Fo r−F−B-vitamin depletion.
However, the extent of hyperhomocysteinemia in response
either to −Fo r−F−B deficiency was different.
Critically, plaque volume was associated primarily with
folic acid deficiency and not with circulating plasma
homocysteine concentrations. Folate deficiency alone
significantly increased plaques in ApoE null mice fed a
HF−F diet. While plaque volume was higher in mice fed a
HF−F−B diet compared with mice fed HF, this was not
significantly different. Mice on this diet grew more slowly
(14%) than mice fed the HF−F diet. This may have retarded
plaque progression in this group. Atherosclerotic plaque
volume was also measured in mice fed either a C−Fo ra
C−F−B diet to establish whether these treatments could
influence early plaque formation. Plaque volume was
similar in all groups fed the low fat diet.
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Fig. 3 The effect of folic acid, B vitamins and fat intake on plasma
homocysteine. Results are means±SEM for n=10 animals per group.
Data not sharing superscript letters differ by P<0.05
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Fig. 2 The effect of folic acid, B vitamins and fat intake on the ratio
of hepatic SAM to SAH. Results are means±SEM for n=10 animals
per group. Data not sharing superscript letters differ by P<0.05
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Fig. 4 The effect of folic acid, B vitamins and fat intake on aortic
plaque development. Results are means±SEM for n=20 animals per
group. Data not sharing superscript letters differ by P<0.05
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circulating homocysteine concentrations in this study,
increased plaque formation is probably not primarily caused
by elevated homocysteine. The effect of hyperhomocystei-
nemia on aortic plaque formation in rodents has been
investigated previously. However, the data are highly
inconsistent, and the magnitude of hyperhomocysteinemia
is profoundly dependent on the dietary regime (Hoffman et
al. 2001; Zhou et al. 2001, 2003). Homocysteine increased
19-fold (from 2.5 μM to 47.0 μM) in ApoE null mice fed a
combined high methionine (HM) and −F−B diet for 8 weeks
(Hoffman et al. 2001). This was associated with a 2-fold
increase in the atherosclerotic plaque area. Critically, plaque
development was unchanged in mice fed a −F−B diet
containing adequate methionine, and homocysteine con-
centrations were surprisingly comparable between treat-
ment and control animals (2.7 μM versus 2.5 μM). Similar
results were described for ApoE null mice fed either
methionine or homocysteine (Zhou et al. 2001). Feeding
animals a HM diet for 10 weeks increased plaques (approx.
2-fold) but without inducing hyperhomocysteinemia
(5.1 μM versus 4.6 μM in chow fed mice; Troen et al.
2003). Conversely, plaque area was unchanged in mice fed
diets that did induce hyperhomocysteinemia (Troen et al.
2003). Total plasma homocysteine was increased 17-fold
(to 86.7 μM) in mice fed a HM−F−B diet and 48-fold (to
243.7 μm) in animals fed only a −F−B vitamin-deficient
diet (Troen et al. 2003). Why homocysteine increased so
markedly in animals fed a −F−B vitamin-depleted diet
relative to animals fed a combined HF−F−B diet remains
unexplained. Moreover, feeding ApoE mice a HM diet has
been shown to induce hyperhomocysteinemia (4-fold and
6-fold after 4 or 18 weeks, respectively) and plaque
formation (60% after 18 weeks) in subsequent studies
(Zhou et al. 2004). While data describing the effects of
homocysteine and plaque formation are highly variable and
contradictory, in general, hyperhomocysteinemia is associ-
ated with an increase in aortic plaque area, but B-vitamin
deficiency is not (Hoffman et al. 2001; Zhou et al. 2001,
2003; Troen et al. 2003). In contrast, we have shown in this
study that low folate, and not primarily plasma homocys-
teine concentration, is linked with atherogenesis in ApoE
null mice fed a HF diet. We believe that the magnitude of
hyperhomocysteinemia induced here may be more physio-
logically relevant to what occurs in humans than described
previously. However, it should be noted that tissue
homocysteine concentrations were not measured, and the
potential detrimental effect of homocysteine accumulation
in the vasculature cannot be excluded.
We went on to determine whether aortic plaque formation,
in response to folate or B-vitamin depletion, was associated
with changes in key intermediates in the methionine cycle
and genome-wide DNA methylation in the vascular tissue
ofthesemice.Genomiccytosinehypomethylationisobserved
in cultured vascular cells and diseased vascular tissue.
5-methylcytosine levels drop 65% in rabbit aorta SMC
explants,while genomicDNAishypomethylatedinadvanced
lesions from ApoE knockout mice, denuded New Zealand
White rabbit aorta and human atherosclerotic lesions com-
pared with normal arteries or arteries with fatty streaks
(Hiltunen et al. 2002). In this study, global DNA methylation
in the liver, aorta, tunica adventitia and heart tissue was
measured by LC MS/MS. Perivascular adventitial adipose is
a metabolically active tissue that secretes vasoresponsive
factors and regulates vascular function (Lohn et al. 2002).
Growth factors produced by rat perivascular adipose tissue
stimulate human vascular SMC growth in culture (Barandier
et al. 2005). We found a weak positive association (P=0.08)
between plasma folate and liver DNA methylation irrespec-
tive of treatment. However, despite a considerable reduction
366 Clin Epigenet (2011) 2:361–368
Table 4 Global DNA methylation in tissues from ApoE mice fed a control (C) or high fat (HF) diet depleted of folic acid (−F) or folic acid and
vitamins B6 and B12 (−F−B) for 16 weeks
Global DNA methylation Control fat High fat
CC −FC −F−BH F H F −FH F −F−B
Aorta 5-methyldeoxycytidine
(ng/μg DNA)
125.5±8.2 (6) 135.7±7.7 (6) 134.4±22. (6) 116.6±11.5 (6) 123.7±7.8 (6) 133.2±15.7 (6)
DNA methylation (%) 3.72±0.06 (6) 3.61±0.05 (6) 3.62±0.07 (6) 3.60±0.05 (6) 3.57±0.04 (6) 3.58±0.07 (6)
Heart 5-methyldeoxycytidine
(ng/μg DNA)
158.9±10.9 (6) 135.3±4.8 (6) 130.8±3.7 (6) 134.7±6.1 (6) 157.0±13.4 (6) 148.8±9.8 (6)
DNA methylation (%) 3.8±0.08 (6) 3.68±0.11 (6) 3.75±0.04 (6) 3.79±0.05 (6) 3.85±0.12 (6) 3.81±0.05 (6)
Aorta tunica adventitia 5-methyldeoxycytidine
(ng/μg DNA)
137.9±12.2 (9) 141.0±8.6 (10) 184.9±22.3 (10) 171.5±13.0 (8) 149.7±20.1 (9) 157.8±16.2 (7)
DNA methylation (%) 4.05±0.11 (10) 3.94±0.15 (10) 4.25±0.10 (10) 4.31±0.12 (8) 3.99±0.10 (9) 3.98±0.13 (7)
Liver 5-methyldeoxycytidine
(ng/μg DNA)
68.1±5.5 (10) 66.6±4.7 (10) 71.4±5.3 (10) 71.5±5.9 (10) 68.4±6.5 (10) 67.6±6.6 (10)
DNA methylation (%) 3.19±0.04 (10) 3.20±0.04 (10) 3.21±0.05 (10) 3.21±0.05 (10) 3.20±0.06 (10) 3.21±0.05 (10)
Values are means±SEM with the number of mice sampled per group in parenthesesin blood and tissue folate and B12 and a significant decrease
in the ratio of hepatic SAM to SAH, neither folate nor
B-vitamin depletion significantly altered genome-wide
cytosine methylation either in the liver or in any of the
vascular tissues examined. Fat intake and homocysteine
may influence DNA methylation. Cytosine DNA methyla-
tion was reported to be lower in atherosclerotic lesions
from ApoE null mice fed a HF Westernised diet compared
with mice fed regular chow (Lund et al. 2004). Maternal
hypercholesterolemia accelerates cardiovascular disease in
the offspring of rodents and rabbits (reviewed in Turunen
et al. 2009), although the mechanism regulating risk
remains to be established. In our study, genomic DNA
methylation in the vasculature of ApoE null mice was
unaffected by feeding on saturated fat and cholesterol
from weaning through to adulthood. Elevated homocys-
teine is associated with DNA hypomethylation in some
MTHFR-deficient mice tissue, but interestingly, not in the
vasculature (Chen et al. 2005). Genomic DNA is also
hypomethylated in blood cells from hyperhomocysteinemic
patients compared with matched controls (Yi et al. 2000;
Ingrosso et al. 2003). Currently, there is no data that folate
itself independently alters global cytosine methylation in
relation to atherosclerosis.
Only genome-wide DNA methylation was measured in
this study. Locus-specific DNA hypomethylation may
promote atherogenicity by upregulating genes involved in
SMC proliferation, lipid deposition and inflammation.
Gene-specific hypomethylation in human atherosclerotic
lesions is associated with increased expression of PDGF,
15-lipoxygenase, IFN-g, MMP-2, MMP-7, TIMP-3, p53
and EC-SOD (Hiltunen and Yla-Herttuala 2003). More-
over, altered DNA methylation and dysregulated gene
expression in vascular endothelial cells (rather than SMC)
may be critical in maintaining vascular function (Matouk
and Marsden 2008). It remains to be established whether
folate deficiency alone influences gene-specific cytosine
methylation in vascular tissue in vivo.
As described earlier, folate status is independently linked
to risk of CVD. Despite this, several recent large-scale
placebo-controlled and randomised folic acid and B-
vitamin human intervention studies (calculated to lower
plasma homocysteine) have failed to demonstrate signifi-
cant benefit (Homocysteine Studies Collaboration 2002;
Splaver et al. 2004; HOPE 2 2006). If aberrant DNA
methylation is causal in deregulating vascular function,
supplementing with B vitamins would equally be expected
to positively influence CVD outcomes in these trials.
However, these studies were designed to investigate the
effects of homocysteine lowering in people with pre-
existing vascular disease, diabetes, stroke or renal failure.
It remains to be established whether B-vitamin supplemen-
tation may be effective in primary prevention.
In conclusion, moderate but prolonged folate deficiency
significantly increased plaque formation in the aorta of
ApoE null mice fed a high fat diet, indicating a positive role
for folate in modulating vascular disease in vivo. This was
not associated with changes in intermediates in the
methionine cycle or with global DNA methylation status
in the vasculature or liver of these animals. Precisely how
folate maintains vascular function remains to be estab-
lished. Our findings do not support the theory that genome-
wide epigenetic changes in the vasculature are causal for
plaque development.
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